VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (1237)	6/17/1997 5:24:00 PM
From: biowa	of 9719

Andy, Thanks. >>...ABTI's response to investor's questions regarding the delay in announcing P3 data on Benefactin. If I've got something wrong here, please correct me...<< You mean other than the fact that its Betafectin (of course if the data is good, those of us long may take to referring to it as Benefactin). I just wanted to add my comment from the ABTI thread, that it turns out the only problem is with mgmt's timelines...AGAIN. Be prepared for the NDA timeline to be wrong. BTW, how come no comment on this thread re: GENZ upping its position in the Tissue Repair tracking stock by 50%? Sure, it was a known option, but it sure represents a strong vote of confidence, especially while awaiting the FDA (Of course they had locked in price of $10/shr, but they didn't have to buy). biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next